Hypertension: all 6,834 studies
Page 66 of 69. Open to participants first (971), then studies with results posted, then the rest; newest registration first within each.
- Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent PacemakersStatus unknownNCT00225667Phase 3
- Observational Study of the Prognosis in Treated Arterial HypertensionCompletedNCT00225030
- Hypertension Telemanagement in African AmericansCompletedNCT00224861Not applicable
- Guideline Adherence for Heart HealthCompletedNCT00224848Phase 2
- PHARES Study: Management of Resistant HypertensionCompletedNCT00224549Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedNCT00221845Phase 3
- Olmesartan as an add-on to Amlodipine in HypertensionCompletedNCT00220233Phase 3
- Amlodipine as add-on to Olmesartan in HypertensionCompletedNCT00220220Phase 3
- The Effect of North American Ginseng on Blood Pressure in Individuals With HypertensionCompletedNCT00219960Phase 3
- Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular HypertensionCompletedNCT00219596Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders PatientsCompletedNCT00219193Phase 3
- Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood PressureCompletedNCT00219180Phase 3
- A Clinical Study to Assess Efficacy and Safety of Aliskiren in the Elderly With High Blood PressureCompletedNCT00219167Phase 3
- A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00219154Phase 3
- A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.CompletedNCT00219128Phase 3
- A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mgCompletedNCT00219115Phase 3
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder PatientsCompletedNCT00219102Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.CompletedNCT00219089Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders PatientsCompletedNCT00219076Phase 3
- A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.CompletedNCT00219063Phase 3
- A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe HypertensionCompletedNCT00219050Phase 3
- Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00219037Phase 3
- Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.CompletedNCT00219024Phase 3
- Physical Exercise in Hypertension, Randomised Clinical TrialCompletedNCT00218972Not applicable
- Community Hypertension Assessment Trial (CHAT)CompletedNCT00217334Not applicable
- Exercise Training in Type 2 Diabetes and HypertensionCompletedNCT00212303Phase 4
- Improving Hypertension Control in East and Central HarlemCompletedNCT00211666Not applicable
- Hypernet- Hypertension ScreeningTerminatedNCT00208845
- Effects of Tetrahydrobiopterin on Blood PressureCompletedNCT00208780Early Phase 1
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and DiabetesTerminatedNCT00208221Phase 3
- Motivational InterviewingTerminatedNCT00208104Not applicable
- Interactive Multirisk-Factor Intervention for Hypertension (HTN) BlacksCompletedNCT00207194Not applicable
- Natrecor for Pulmonary Hypertension in Lung TransplantsCompletedNCT00205426Phase 4
- A Team Model of Hypertension Care in African AmericansCompletedNCT00205153Not applicable
- Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial RelaxationCompletedNCT00204984Not applicable
- Rationale and Design for Shiga Microalbuminuria Reduction TrialStatus unknownNCT00202618Phase 4
- S90652 in Paediatric HypertensionCompletedNCT00202592Phase 2
- S90652 in Paediatric HypertensionCompletedNCT00202553Phase 2
- Spanish Cohort for the Study of the Effect of CPAP in Hypertension (CEPECTA)Status unknownNCT00202527Not applicable
- Home Blood Pressure Monitoring and Blood Pressure ControlCompletedNCT00202137Not applicable
- Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy AdherenceCompletedNCT00201149Not applicable
- Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease RiskCompletedNCT00201136Phase 2
- Physician Uncertainty Reduction for HypertensionCompletedNCT00201084Not applicable
- Team Management of High Blood PressureCompletedNCT00201045Not applicable
- Improving Adherence to Blood Pressure GuidelinesCompletedNCT00201019Not applicable
- Effectiveness of a Low Carbohydrate Diet Versus a High Carbohydrate Diet in Promoting Weight Loss and Improved HealthCompletedNCT00200720Phase 2
- A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive PatientsCompletedNCT00200499Phase 3
- A Study of the Safety and Efficacy of Nebivolol in Hypertensive PatientsCompletedNCT00200473Phase 3
- A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive PatientsCompletedNCT00200460Phase 3
- A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With HypertensionCompletedNCT00200434Phase 3
- A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate HypertensionCompletedNCT00200421Phase 2
- Hypertension Control Based on Home Blood PressureStatus unknownNCT00198562Phase 4
- Psychosocial Determinants of Medication Adherence in Hypertensive African AmericansStatus unknownNCT00195182
- Treatment Targets for Chronic Hypertension in PregnancyWithdrawnNCT00194974Phase 1/2
- Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese PersonsCompletedNCT00194428Phase 1/2
- Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular DiseaseCompletedNCT00190580Phase 4
- Serotonin Transporter Inhibitor Escitalopram in Pulmonary HypertensionCompletedNCT00190333Phase 3
- CHIPS (Control of Hypertension in Pregnancy Study): A Pilot TrialCompletedNCT00187395Not applicable
- Treatment of Insulin Resistance in Hypertensive, Obese AdolescentsTerminatedNCT00185705Not applicable
- Olmesartan in Essential HypertensionCompletedNCT00185172Phase 3
- Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCompletedNCT00185133Phase 3
- Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel BlockerCompletedNCT00185120Phase 4
- A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinCompletedNCT00185094Phase 4
- An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With HypertensionCompletedNCT00185068Phase 4
- The Effect of Statin Use on Vascular Function in Hypertensive SubjectsTerminatedNCT00181181Phase 4
- Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive PatientsCompletedNCT00179543Phase 2
- The Autonomic Nervous System and ObesityCompletedNCT00179023Phase 1
- Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in ChildrenCompletedNCT00178490Phase 1
- The Effect of Hibiscus Sabdariffa L. Tea on Blood PressureCompletedNCT00175110Phase 1/2
- Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And DyslipidemiaCompletedNCT00174330Phase 4
- Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.CompletedNCT00174304Phase 4
- Collection of Blood and Urine Specimens From Volunteers Utilizing Health Examination ServicesStatus unknownNCT00173940
- A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential HypertensionStatus unknownNCT00173667Phase 4
- Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary HypertensionStatus unknownNCT00173537Not applicable
- Angiotensinogen Gene and HypertensionStatus unknownNCT00173004
- The Relation Between Serum Level of Amioterminal Propeptide of Type I Procollagen and Diastolic Dysfunction in Hypertensive Patients Without Diabetes MellitusCompletedNCT00172406
- Hypertension and Cardiovascular Risk FactorsCompletedNCT00171782Phase 4
- Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.CompletedNCT00171756Phase 4
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNCT00171561Phase 4
- Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe HypertensionCompletedNCT00171535Phase 3
- Comparison of Two Treatment Strategies in Hypertensive PatientsCompletedNCT00171444Phase 4
- A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mgCompletedNCT00171405Phase 3
- A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.CompletedNCT00171366Phase 3
- A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood PressureCompletedNCT00171353Phase 4
- Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial DysfunctionCompletedNCT00171327Phase 4
- VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal WomenCompletedNCT00171132Phase 4
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+BenazeprilTerminatedNCT00171119Phase 4
- A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and HypercholesterolemiaCompletedNCT00171093Phase 3
- VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term HemodialysisCompletedNCT00171080Phase 3
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaCompletedNCT00171067Phase 3
- A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of AgeCompletedNCT00171041Phase 3
- A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have HypertensionCompletedNCT00171028Phase 3
- VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan MedoxomilCompletedNCT00171015Phase 3
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine AloneCompletedNCT00171002Phase 3
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170989Phase 3
- A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With HypertensionCompletedNCT00170976Phase 3
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan AloneCompletedNCT00170963Phase 3
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic SyndromeCompletedNCT00170937Phase 4
- To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.CompletedNCT00170924Phase 4